Furthermore, the tumor lesions from DEN-treated TG mice showed weaker Slamf7 and Nkg2d immunostaining and stronger Tigit and nuclear Ki67 staining compared with non-tumor areas, although TM4SF5 staining was comparable between tumor and non-tumor regions (Fig. 1k). This evidence concerns the gene KLRK1 and neoplasm.